Nihchal Israni Foundation Profile
Key Indicators
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 5.21%
(FY 2023)
- Profit 9.44%
(FY 2023)
- Ebitda -4.70%
(FY 2023)
- Net Worth 77.37%
(FY 2023)
- Total Assets 77.37%
(FY 2023)
About Nihchal Israni Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Suresh Mahalingam, Mahinder Punwani, Manoj Israni, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85191MH2013NPL246233
- Company No.
246233
- Company Classification
Private Not For Profit Company
- Incorporation Date
26 Jul 2013
- Date of AGM
31 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nihchal Israni Foundation?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Mahalingam  | Director | 28-Sep-2019 | Current |
| Mahinder Punwani | Director | 28-Jul-2016 | Current |
| Manoj Israni | Director | 28-Jun-2021 | Current |
| Nihchal Israni | Director | 26-Jul-2013 | Current |
| Rajendra Padhye | Director | 26-Jul-2013 | Current |
Financial Performance and Corporate Structure Insights of Nihchal Israni Foundation.
Nihchal Israni Foundation, for the financial year ended 2023, experienced modest growth in revenue, with a 5.21% increase. The company also saw a slight improvement in profitability, with a 9.44% increase in profit. The company's net worth Soared by an impressive increase of 77.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nihchal Israni Foundation?
Unlock access to Nihchal Israni Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Blue Cross Laboratories Private LimitedActive 44 years 5 monthsManoj Israni, Nihchal Israni and 1 more are mutual person
Hariman Laboratories Pvt LtdActive 35 years 4 monthsSuresh Mahalingam, Mahinder Punwani and 2 more are mutual person
- Niko Management Services Private LimitedActive 34 years 10 months
Suresh Mahalingam and Manoj Israni are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nihchal Israni Foundation?
Unlock and access historical data on people associated with Nihchal Israni Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nihchal Israni Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nihchal Israni Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
